Calidi Biotherapeutics, Inc. CLDI · SEC Filings

website

Calidi Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on immuno-oncology, d...

Price0.7331

Market Cap2.69 M

Float3.66 M

CountryUS

SectorHealthcare

ExchangeAMEX

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

Sep 17, 2026

424B5

REGISTERED OFFERING

Mar 6, 2026

424B5

PENDING FIXED PRICE OFFERING | Bank: Ladenburg Thalmann

Mar 5, 2026

424B4

Aug 21, 2025

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 6,935,579 | Warrants amount: 6,595,000 | .70

Jul 10, 2025

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 79,987,500 | Warrants amount: 759,875 | .70

Jul 10, 2025

Registrations

TYPE

HEADLINE

FILED AT

S-3MEF

March 2026 SHELF

Mar 5, 2026

S-1

OFFERING - Ladenburg Thalmann

Aug 15, 2025

S-3

SHARE RESALE REGISTRATION

Jul 18, 2025

S-1

SHARE RESALE REGISTRATION

Jul 3, 2025

DRS

Form DRS - Draft Registration Statement

Jul 2, 2025

S-3

Form S-3 - Registration statement under Securities Act of 1933

Jan 10, 2025

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Jun 5, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 29, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 29, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Apr 17, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

May 23, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

May 23, 2025

Ownerships

TYPE

HEADLINE

FILED AT

Peoples George (Reporting)

Aug 19, 2026

Leftwich Scott (Reporting)

Aug 19, 2026

Stewart Alan R. (Reporting)

Aug 19, 2026

Jackson Andrew C. (Reporting)

Aug 19, 2026

Schoeneck James A (Reporting)

Aug 19, 2026

Poma Eric E (Reporting)

Aug 19, 2026

Other

TYPE

HEADLINE

FILED AT